Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea
Clinical trial NCT07606820 · COMPLETED
Trial details
- NCT number
- NCT07606820
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-29
- Primary completion
- 2026-04-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.